Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) by Supposed Coronary Thromboembolism by Patent Foramen Ovale (PFO). Should the PFO be Closed?

Clinic of the Cardiology and Intensive Care Unit, Clinic of Ingolstadt, Germany

*Corresponding author: Mourad Haj Abdo, Clinic of the Cardiology and Intensive Care Unit, Clinic of Ingolstadt, Germany, Tel: +49491741985933; E-mail: [email protected].

Received Date: Jaunary 19, 2023

Published Date: Jaunary 31, 2023

Citation: Mourad HA, et al. (2023). Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) by Supposed Coronary Thromboembolism by Patent Foramen Ovale (PFO). Should the PFO be Closed? Mathews J Case Rep. 8(1):85.

Copyrights: Mourad HA, et al. © (2023).

INTRODUCTION

Myocardial infarction is defined as the presence of myocardial injury with elevated levels of heart biomarkers [1]. The important stones in the diagnosis are electrocardiogram, coronary care units, coronary angiography, reperfusion therapies, and troponin assays [2,3]. MINOCA has many causes: plaque disruption, coronary artery spasm, coronary thromboembolism, coronary dissection, myocarditis, and takotsubo cardiomyopathy [4]. In our case, we introduce a patient, who had a myocardial infarction with ST elevation at admission. She had a coronary angiogram, coronary artery disease, and microvascular disease were excluded. As a cause of myocardial infarction, coronary thromboembolism is supposed.